denkapparat Operations GmbH Buys New Position in Humana Inc. (NYSE:HUM)

denkapparat Operations GmbH bought a new position in Humana Inc. (NYSE:HUM) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,272 shares of the insurance provider’s stock, valued at approximately $323,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Dynamic Technology Lab Private Ltd acquired a new position in shares of Humana during the 3rd quarter valued at $404,000. Independent Advisor Alliance raised its holdings in shares of Humana by 68.3% during the third quarter. Independent Advisor Alliance now owns 2,141 shares of the insurance provider’s stock valued at $678,000 after purchasing an additional 869 shares during the period. Bank of Montreal Can boosted its position in shares of Humana by 18.4% during the 3rd quarter. Bank of Montreal Can now owns 189,168 shares of the insurance provider’s stock worth $60,452,000 after purchasing an additional 29,460 shares in the last quarter. FMR LLC boosted its position in shares of Humana by 23.4% during the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock worth $1,073,387,000 after purchasing an additional 643,291 shares in the last quarter. Finally, Avestar Capital LLC increased its position in Humana by 34.8% in the 3rd quarter. Avestar Capital LLC now owns 1,372 shares of the insurance provider’s stock valued at $435,000 after buying an additional 354 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.37% of the company’s stock.

Analyst Ratings Changes

HUM has been the topic of several recent research reports. Morgan Stanley cut their price target on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 12th. Truist Financial boosted their price target on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Piper Sandler raised their price objective on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research note on Wednesday, January 15th. Royal Bank of Canada reiterated an “outperform” rating and set a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 18th. Eighteen analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $285.68.

Humana Trading Down 0.2 %

NYSE:HUM opened at $270.04 on Friday. The firm’s 50 day moving average is $270.51 and its 200 day moving average is $274.93. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The stock has a market capitalization of $32.59 billion, a PE ratio of 27.14, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM) last issued its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Sell-side analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.31%. Humana’s payout ratio is 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.